PEComa with Transcription Factor E3 Overexpression: A Diagnostic and Therapeutic Challenge
PEComa with transcription factor E3 overexpression, most commonly through gene rearrangement, represents a biologically distinct subset of disease. We present here an illustrative case to highlight its diagnostic and therapeutic challenge in the context of potential pathogenic signaling pathways.
Main Authors: | Richard J. Lin, Jonathan Melamed, Jennifer Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2017-06-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | http://prod.karger.com/Article/FullText/477434 |
Similar Items
-
Laparoscopic excision of infra-renal PEComa
by: Amol H Bhanushali, et al.
Published: (2015-01-01) -
Metastatic cardiac PEComa presenting as a hemorrhagic pleural effusion: Case presentation and review of literature
by: Sassine Ghanem, et al.
Published: (2021-03-01) -
Perivascular epithelioid cell tumors (PEComa) of the female genital tract: A challenging question for gynaecologic oncologist and pathologist
by: Angiolo Gadducci, et al.
Published: (2020-08-01) -
A Rare Case of PEComa of the Liver
by: Abigail Attard, et al.
Published: (2020-10-01) -
CD10-Positive Cutaneous PEComa: An Extremely Rare Skin Tumour
by: Simon Ueberschaar, et al.
Published: (2020-11-01)